# Strategic inquiry into pre‐submission activities organised by the European Medicines Agency (OI/7/2017/KR). 
- Author: European Ombudsman
- Date: 2017-07-17T00:00+02:00[Europe/Paris]
- [URL](https://www.ombudsman.europa.eu/en/opening-summary/en/81524)
---
The European Ombudsman, Emily O'Reilly, has opened an inquiry into the pre-submission activities that the European Medicines Agency (EMA) offers to individual medicine developers before the Agency receives applications for marketing authorisations from them.